These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 16061682

  • 21. Enhanced lung cancer cell killing by the combination of selenium and ionizing radiation.
    Shin SH, Yoon MJ, Kim M, Kim JI, Lee SJ, Lee YS, Bae S.
    Oncol Rep; 2007 Jan; 17(1):209-16. PubMed ID: 17143500
    [Abstract] [Full Text] [Related]

  • 22. The HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin modulates radiosensitivity by downregulating serine/threonine kinase 38 via Sp1 inhibition.
    Enomoto A, Fukasawa T, Takamatsu N, Ito M, Morita A, Hosoi Y, Miyagawa K.
    Eur J Cancer; 2013 Nov; 49(16):3547-58. PubMed ID: 23886587
    [Abstract] [Full Text] [Related]

  • 23. Gleevec-mediated inhibition of Rad51 expression and enhancement of tumor cell radiosensitivity.
    Russell JS, Brady K, Burgan WE, Cerra MA, Oswald KA, Camphausen K, Tofilon PJ.
    Cancer Res; 2003 Nov 01; 63(21):7377-83. PubMed ID: 14612536
    [Abstract] [Full Text] [Related]

  • 24. Surface charge and hydrophobicity determine ErbB2 binding to the Hsp90 chaperone complex.
    Xu W, Yuan X, Xiang Z, Mimnaugh E, Marcu M, Neckers L.
    Nat Struct Mol Biol; 2005 Feb 01; 12(2):120-6. PubMed ID: 15643424
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Adenovirus-mediated siRNA targeting Mcl-1 gene increases radiosensitivity of pancreatic carcinoma cells in vitro and in vivo.
    Guoan X, Hanning W, Kaiyun C, Hao L.
    Surgery; 2010 Apr 01; 147(4):553-61. PubMed ID: 20004446
    [Abstract] [Full Text] [Related]

  • 28. Frequency and clinicopathologic correlates of ErbB1, ErbB2, and ErbB3 immunoreactivity in urothelial tumors of upper urinary tract.
    Tsai YS, Tzai TS, Chow NH, Wu CL.
    Urology; 2005 Dec 01; 66(6):1197-202. PubMed ID: 16360440
    [Abstract] [Full Text] [Related]

  • 29. Muc4 is required for activation of ErbB2 in signet ring carcinoma cell lines.
    Yokoyama A, Shi BH, Kawai T, Konishi H, Andoh R, Tachikawa H, Ihara S, Fukui Y.
    Biochem Biophys Res Commun; 2007 Mar 30; 355(1):200-3. PubMed ID: 17292332
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells.
    Kim KK, Lee JJ, Yang Y, You KH, Lee JH.
    Carcinogenesis; 2008 Apr 30; 29(4):704-12. PubMed ID: 18258606
    [Abstract] [Full Text] [Related]

  • 32. Abrogation of heat shock protein 70 induction as a strategy to increase antileukemia activity of heat shock protein 90 inhibitor 17-allylamino-demethoxy geldanamycin.
    Guo F, Rocha K, Bali P, Pranpat M, Fiskus W, Boyapalle S, Kumaraswamy S, Balasis M, Greedy B, Armitage ES, Lawrence N, Bhalla K.
    Cancer Res; 2005 Nov 15; 65(22):10536-44. PubMed ID: 16288046
    [Abstract] [Full Text] [Related]

  • 33. Autophagy inhibition sensitizes multiple myeloma cells to 17-dimethylaminoethylamino-17-demethoxygeldanamycin-induced apoptosis.
    Palacios C, Martín-Pérez R, López-Pérez AI, Pandiella A, López-Rivas A.
    Leuk Res; 2010 Nov 15; 34(11):1533-8. PubMed ID: 20667592
    [Abstract] [Full Text] [Related]

  • 34. The kinase Mirk/Dyrk1B mediates cell survival in pancreatic ductal adenocarcinoma.
    Deng X, Ewton DZ, Li S, Naqvi A, Mercer SE, Landas S, Friedman E.
    Cancer Res; 2006 Apr 15; 66(8):4149-58. PubMed ID: 16618736
    [Abstract] [Full Text] [Related]

  • 35. Pharmacokinetic-pharmacodynamic relationships for the heat shock protein 90 molecular chaperone inhibitor 17-allylamino, 17-demethoxygeldanamycin in human ovarian cancer xenograft models.
    Banerji U, Walton M, Raynaud F, Grimshaw R, Kelland L, Valenti M, Judson I, Workman P.
    Clin Cancer Res; 2005 Oct 01; 11(19 Pt 1):7023-32. PubMed ID: 16203796
    [Abstract] [Full Text] [Related]

  • 36. Heat shock protein 90 and ErbB2 in the cardiac response to doxorubicin injury.
    Gabrielson K, Bedja D, Pin S, Tsao A, Gama L, Yuan B, Muratore N.
    Cancer Res; 2007 Feb 15; 67(4):1436-41. PubMed ID: 17308081
    [Abstract] [Full Text] [Related]

  • 37. A role for Janus kinases in crosstalk between ErbB3 and the interferon-alpha signaling complex in myeloma cells.
    Walters DK, Jelinek DF.
    Oncogene; 2004 Feb 12; 23(6):1197-205. PubMed ID: 14647450
    [Abstract] [Full Text] [Related]

  • 38. Down-regulation of RIP expression by 17-dimethylaminoethylamino-17-demethoxygeldanamycin promotes TRAIL-induced apoptosis in breast tumor cells.
    Palacios C, López-Pérez AI, López-Rivas A.
    Cancer Lett; 2010 Jan 28; 287(2):207-15. PubMed ID: 19632771
    [Abstract] [Full Text] [Related]

  • 39. The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation.
    Holbro T, Beerli RR, Maurer F, Koziczak M, Barbas CF, Hynes NE.
    Proc Natl Acad Sci U S A; 2003 Jul 22; 100(15):8933-8. PubMed ID: 12853564
    [Abstract] [Full Text] [Related]

  • 40. HSP90 inhibition blocks ERBB3 and RET phosphorylation in myxoid/round cell liposarcoma and causes massive cell death in vitro and in vivo.
    Safavi S, Järnum S, Vannas C, Udhane S, Jonasson E, Tomic TT, Grundevik P, Fagman H, Hansson M, Kalender Z, Jauhiainen A, Dolatabadi S, Stratford EW, Myklebost O, Eriksson M, Stenman G, Schneider-Stock R, Ståhlberg A, Åman P.
    Oncotarget; 2016 Jan 05; 7(1):433-45. PubMed ID: 26595521
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.